Page last updated: 2024-08-24

chromic phosphate and Local Neoplasm Recurrence

chromic phosphate has been researched along with Local Neoplasm Recurrence in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (57.14)	18.7374
1990's	1 (14.29)	18.2507
2000's	2 (28.57)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alvarez, RD; Benda, JA; Bundy, BN; Clarke-Pearson, DL; Long, HJ; Stehman, FB; Varia, MA	1
Alberts, DS; Brady, MF; Hurteau, J; Lentz, SS; Long, HJ; Mayer, AR; Nieberg, RK; Young, RC	1
Berchuck, A; Clarke-Pearson, DL; Dodge, R; Soper, JT	1
Austin, JM; Hatch, KD; Kim, RY; Partridge, EE; Potter, ME; Shingleton, HM; Soong, SJ	1
Bakshi, S; Emrich, LJ; Lele, SB; Parthasarathy, KL; Piver, MS	1
Ehrlich, CE; Hornback, NB; Reddy, S; Stehman, FB; Sutton, GP	1
Clarke-Pearson, DL; Creasman, WT; Johnston, WW; Soper, JT; Sullivan, DC; Vergadoro, F	1

Trials

2 trial(s) available for chromic phosphate and Local Neoplasm Recurrence

Article	Year
Intraperitoneal radioactive phosphorus (32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma: a randomized trial of the Gynecologic Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Aug-01, Volume: 21, Issue:15 Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Chi-Square Distribution; Chromium Compounds; Combined Modality Therapy; Female; Humans; Infusions, Parenteral; Laparotomy; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Proportional Hazards Models; Prospective Studies; Survival Analysis; Treatment Outcome	2003
Adjuvant treatment for early ovarian cancer: a randomized phase III trial of intraperitoneal 32P or intravenous cyclophosphamide and cisplatin--a gynecologic oncology group study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Dec-01, Volume: 21, Issue:23 Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Endometrioid; Chemotherapy, Adjuvant; Chromium Compounds; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cystadenocarcinoma, Serous; Disease-Free Survival; Female; Humans; Injections, Intraperitoneal; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Prospective Studies; Survival Rate; Treatment Outcome	2003

Article

Year

Intraperitoneal radioactive phosphorus (32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma: a randomized trial of the Gynecologic Oncology Group.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Aug-01, Volume: 21, Issue:15

Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Chi-Square Distribution; Chromium Compounds; Combined Modality Therapy; Female; Humans; Infusions, Parenteral; Laparotomy; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Proportional Hazards Models; Prospective Studies; Survival Analysis; Treatment Outcome

2003

Adjuvant treatment for early ovarian cancer: a randomized phase III trial of intraperitoneal 32P or intravenous cyclophosphamide and cisplatin--a gynecologic oncology group study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Dec-01, Volume: 21, Issue:23

Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Endometrioid; Chemotherapy, Adjuvant; Chromium Compounds; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cystadenocarcinoma, Serous; Disease-Free Survival; Female; Humans; Injections, Intraperitoneal; Middle Aged; Neoplasm Recurrence, Local; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Prospective Studies; Survival Rate; Treatment Outcome

2003

Other Studies

5 other study(ies) available for chromic phosphate and Local Neoplasm Recurrence

Article	Year
Adjuvant therapy with intraperitoneal chromic phosphate (32P) in women with early ovarian carcinoma after comprehensive surgical staging. Obstetrics and gynecology, 1992, Volume: 79, Issue:6 Topics: Adult; Aged; Antineoplastic Agents; Chemotherapy, Adjuvant; Chromium; Chromium Compounds; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Phosphates; Survival Analysis	1992
Intraperitoneal chromic phosphate in ovarian cancer: risks and benefits. Gynecologic oncology, 1989, Volume: 32, Issue:3 Topics: Chromium; Chromium Compounds; Female; Humans; Instillation, Drug; Neoplasm Recurrence, Local; Ovarian Neoplasms; Peritoneal Cavity; Phosphates; Phosphorus Radioisotopes	1989
Five and ten year estimated survival and disease-free rates after intraperitoneal chromic phosphate; stage I ovarian adenocarcinoma. American journal of clinical oncology, 1988, Volume: 11, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Chromium; Chromium Compounds; Female; Humans; Injections, Intraperitoneal; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Prospective Studies; Time Factors	1988
Ovarian carcinoma: adjuvant treatment with P-32. Radiology, 1987, Volume: 165, Issue:1 Topics: Brachytherapy; Carcinoma; Chromium; Chromium Compounds; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Phosphates; Phosphorus Radioisotopes; Posture; Radiotherapy Dosage	1987
Intraperitoneal chromic phosphate P 32 suspension therapy of malignant peritoneal cytology in endometrial carcinoma. American journal of obstetrics and gynecology, 1985, Sep-15, Volume: 153, Issue:2 Topics: Adenocarcinoma; Brachytherapy; Catheters, Indwelling; Chromium; Chromium Compounds; Female; Follow-Up Studies; Humans; Hysterectomy; Injections, Intraperitoneal; Neoplasm Recurrence, Local; Neoplasm Staging; Peritoneal Neoplasms; Phosphates; Phosphorus Radioisotopes; Prognosis; Uterine Neoplasms	1985